Pcos Risk Calculator
Assess PCOS risk from symptoms, lab values, and Rotterdam diagnostic criteria. Enter values for instant results with step-by-step formulas.
Calculator
Adjust values & calculateMenstrual Symptoms
Androgen-Related Symptoms
Metabolic Symptoms
- - Elevated BMI
- - Pelvic ultrasound
- - Thyroid function tests (TSH)
- - Prolactin levels
- - Lipid panel
Formula
PCOS diagnosis requires meeting at least 2 of 3 Rotterdam criteria after excluding other causes. The risk score weights each symptom and finding by its diagnostic significance. Phenotype classification (A through D) depends on which specific criteria are met and determines metabolic risk profile.
Last reviewed: January 2026
Worked Examples
Example 1: Classic PCOS Presentation
Example 2: Mild PCOS Variant
Background & Theory
The Pcos Risk Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Pcos Risk Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Formula
Rotterdam Diagnosis = 2 of 3 criteria (Oligo/anovulation + Hyperandrogenism + Polycystic Ovaries)
PCOS diagnosis requires meeting at least 2 of 3 Rotterdam criteria after excluding other causes. The risk score weights each symptom and finding by its diagnostic significance. Phenotype classification (A through D) depends on which specific criteria are met and determines metabolic risk profile.
Worked Examples
Example 1: Classic PCOS Presentation
Problem: A 28-year-old woman has irregular periods every 45-60 days, moderate facial hair growth, persistent acne, BMI of 31, and ultrasound showing polycystic ovaries. Testosterone is elevated.
Solution: Rotterdam criteria assessment:\n1. Oligo-ovulation: YES (irregular periods every 45-60 days)\n2. Hyperandrogenism: YES (clinical: hirsutism + acne; biochemical: elevated testosterone)\n3. Polycystic ovaries: YES (confirmed on ultrasound)\nAll 3 criteria met = Phenotype A (Classic PCOS - Full)\nRisk score: irregular periods (15) + hirsutism (12) + acne (8) + PCO (15) + elevated T (15) + BMI 30+ (10) = 75\nMetabolic risks: Elevated BMI, likely insulin resistance
Result: Phenotype A (Classic PCOS) | 3/3 Rotterdam criteria | Risk Score: 75 (Very High Risk)
Example 2: Mild PCOS Variant
Problem: A 24-year-old with regular periods, mild acne, and polycystic ovaries on ultrasound. Normal BMI of 22, normal testosterone, no hirsutism.
Solution: Rotterdam criteria assessment:\n1. Oligo-ovulation: NO (regular periods)\n2. Hyperandrogenism: YES (clinical: acne present, though mild)\n3. Polycystic ovaries: YES (confirmed on ultrasound)\n2 of 3 criteria met = Phenotype C (Ovulatory PCOS)\nRisk score: acne (8) + PCO (15) = 23\nMetabolic risks: Minimal - normal BMI, no insulin resistance markers\nThis is the mildest phenotype with lowest metabolic risk
Result: Phenotype C (Ovulatory PCOS) | 2/3 Rotterdam criteria | Risk Score: 23 (Moderate Risk)
Frequently Asked Questions
What is PCOS and how common is it among women of reproductive age?
Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age, with prevalence estimates ranging from 6 to 20 percent depending on the diagnostic criteria used. It is characterized by a combination of hormonal imbalances, metabolic dysfunction, and reproductive irregularities. PCOS results from excess androgen production by the ovaries and adrenal glands, often accompanied by insulin resistance that further stimulates androgen production. The condition is not simply about having cysts on the ovaries, as the name misleadingly suggests, but rather involves a complex interplay of genetic, hormonal, and environmental factors. PCOS is the leading cause of anovulatory infertility and significantly increases the risk of type 2 diabetes, cardiovascular disease, and endometrial cancer if left unmanaged.
What are the Rotterdam criteria for diagnosing PCOS?
The Rotterdam criteria, established in 2003 by the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine, require that two of three criteria be present for a PCOS diagnosis after excluding other conditions. The three criteria are: oligo-ovulation or anovulation (irregular or absent menstrual cycles), clinical or biochemical signs of hyperandrogenism (excess male hormones manifesting as acne, hirsutism, hair loss, or elevated testosterone levels), and polycystic ovarian morphology on ultrasound (12 or more follicles measuring 2 to 9 mm in diameter, or an ovarian volume exceeding 10 mL). This system replaced the earlier NIH criteria that required both irregular periods and hyperandrogenism. The Rotterdam criteria identify four distinct phenotypes, with Phenotype A being the most metabolically severe and Phenotype D being the mildest.
How does insulin resistance contribute to PCOS development?
Insulin resistance plays a central role in PCOS pathophysiology for approximately 70 to 80 percent of affected women. When cells become resistant to insulin, the pancreas compensates by producing more insulin (hyperinsulinemia). Elevated insulin directly stimulates ovarian theca cells to produce excess androgens and reduces the liver production of sex hormone-binding globulin (SHBG), which increases free testosterone levels. High insulin also impairs normal follicular development, leading to anovulation and the accumulation of small antral follicles that give the ovaries their polycystic appearance. Insulin resistance in PCOS appears to involve a post-receptor signaling defect specific to the metabolic pathway while the mitogenic pathway remains intact, creating a unique form of selective insulin resistance. This is why weight management and insulin-sensitizing medications like metformin are often first-line treatments for PCOS.
What are the different PCOS phenotypes and why do they matter?
PCOS is classified into four phenotypes based on which Rotterdam criteria are present, and each carries different metabolic and reproductive risk profiles. Phenotype A (classic PCOS) meets all three criteria and carries the highest risk of metabolic complications including insulin resistance, dyslipidemia, and type 2 diabetes. Phenotype B (non-polycystic ovary PCOS) has irregular periods and hyperandrogenism without polycystic ovaries and carries similar metabolic risk to Phenotype A. Phenotype C (ovulatory PCOS) has hyperandrogenism and polycystic ovaries but regular cycles, with moderate metabolic risk. Phenotype D (non-hyperandrogenic PCOS) has irregular periods and polycystic ovaries without androgen excess and carries the lowest metabolic risk. Understanding phenotype helps clinicians tailor treatment approaches and counseling about long-term health risks.
What blood tests are used to evaluate suspected PCOS?
A comprehensive PCOS workup includes several blood tests to confirm diagnosis and rule out other conditions. Total and free testosterone levels assess biochemical hyperandrogenism, with free testosterone being more sensitive. DHEA-S (dehydroepiandrosterone sulfate) evaluates adrenal androgen production. 17-hydroxyprogesterone screens for non-classic congenital adrenal hyperplasia, which can mimic PCOS. Thyroid function tests (TSH and free T4) rule out thyroid disorders that can cause menstrual irregularity. Prolactin levels exclude hyperprolactinemia. Fasting glucose and insulin levels or an oral glucose tolerance test assess insulin resistance. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) ratio is often elevated in PCOS, typically above 2:1. Anti-Mullerian hormone (AMH) is often elevated and correlates with antral follicle count. A lipid panel evaluates cardiovascular risk factors commonly altered in PCOS.
How does PCOS affect fertility and what treatments are available?
PCOS is the most common cause of anovulatory infertility, accounting for approximately 80 percent of cases. The hormonal imbalances prevent regular ovulation, making conception difficult but not impossible. Many women with PCOS can conceive with appropriate treatment. First-line ovulation induction treatment is letrozole (an aromatase inhibitor), which has replaced clomiphene citrate as the preferred option based on evidence of higher live birth rates. Weight loss of even 5 to 10 percent of body weight can restore ovulation in overweight women with PCOS. Metformin may improve ovulation rates when combined with lifestyle modifications. Gonadotropin injections are second-line treatment for women who do not respond to oral medications. In vitro fertilization (IVF) is reserved for cases refractory to other treatments. Women with PCOS undergoing IVF have a higher risk of ovarian hyperstimulation syndrome and require careful monitoring and modified protocols.
References
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy